Animal Models of Pneumococcal pneumonia

被引:25
作者
Borsa, Noemi [1 ,2 ,3 ]
Di Pasquale, Marta [1 ,2 ]
Restrepo, Marcos I. [3 ,4 ]
机构
[1] Univ Milan, Dept Pathophysiol & Transplantat, Dept Internal Med, Resp Unit, I-20122 Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Adult Cyst Fibrosis Ctr, I-20122 Milan, Italy
[3] Univ Texas Hlth Sci Ctr San Antonio, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA
[4] South Texas Vet Hlth Care Syst, San Antonio, TX 78229 USA
关键词
pneumonia; S; pneumoniae; animal model; antibiotic resistance; vaccine; RESISTANT STREPTOCOCCUS-PNEUMONIAE; COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT INFECTION; LUNG INFLAMMATORY RESPONSE; SURFACE PROTEIN-A; IN-VIVO EFFICACY; PENICILLIN-RESISTANT; MOUSE MODEL; INVASIVE DISEASE; INCREASED SUSCEPTIBILITY;
D O I
10.3390/ijms20174220
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Streptococcus pneumoniae remains the most common bacterial pathogen causing lower respiratory tract infections and is a leading cause of morbidity and mortality worldwide, especially in children and the elderly. Another important aspect related to pneumococcal infections is the persistent rate of penicillin and macrolide resistance. Therefore, animal models have been developed to better understand the pathogenesis of pneumococcal disease and test new therapeutic agents and vaccines. This narrative review will focus on the characteristics of the different animal pneumococcal pneumonia models. The assessment of the different animal models will include considerations regarding pneumococcal strains, microbiology properties, procedures used for bacterial inoculation, pathogenesis, clinical characteristics, diagnosis, treatment, and preventive approaches.
引用
收藏
页数:20
相关论文
共 141 条
  • [1] Amoxicillin is effective against penicillin-resistant Streptococcus pneumoniae strains in a mouse pneumonia model simulating human pharmacokinetics
    Abgueguen, Pierre
    Azoulay-Dupuis, Esther
    Noel, Violaine
    Moine, Pierre
    Rieux, Veronique
    Fantin, Bruno
    Bedos, Jean-Pierre
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) : 208 - 214
  • [2] Role of pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats
    Alcantara, RB
    Preheim, LC
    Gentry, MJ
    [J]. INFECTION AND IMMUNITY, 1999, 67 (06) : 2862 - 2866
  • [3] Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia
    Alcantara, RB
    Preheim, LC
    Gentry-Nielsen, MJ
    [J]. INFECTION AND IMMUNITY, 2001, 69 (06) : 3569 - 3575
  • [4] Pneumococcal Gene Complex Involved in Resistance to Extracellular Oxidative Stress
    Andisi, Vahid Farshchi
    Hinojosa, Cecilia A.
    de Jong, Anne
    Kuipers, Oscar P.
    Orihuela, Carlos J.
    Bijlsma, Jetta J. E.
    [J]. INFECTION AND IMMUNITY, 2012, 80 (03) : 1037 - 1049
  • [5] Hydrogen Sulfide Donor NaHS Reduces Organ Injury in a Rat Model of Pneumococcal Pneumosepsis, Associated with Improved Bio-Energetic Status
    Aslami, Hamid
    Pulskens, Wilco P.
    Kuipers, Maria T.
    Bos, Aafkeline P.
    van Kuilenburg, Andre B. P.
    Wanders, Ronald J. A.
    Roelofsen, Jeroen
    Roelofs, Joris J. T. H.
    Kerindongo, Raphaela P.
    Beurskens, Charlotte J. P.
    Schultz, Marcus J.
    Kulik, Wim
    Weber, Nina C.
    Juffermans, Nicole P.
    [J]. PLOS ONE, 2013, 8 (05):
  • [6] Efficacy of BB-83698, a novel peptide deformylase inhibitor, in a mouse model of pneumococcal pneumonia
    Azoulay-Dupuis, E
    Mohler, J
    Bédos, JP
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 80 - 85
  • [7] Relationship between capsular type, penicillin susceptibility, and virulence of human Streptococcus pneumoniae isolates in mice
    Azoulay-Dupuis, E
    Rieux, V
    Muffat-Joly, M
    Bédos, JP
    Vallée, E
    Rivier, C
    Isturiz, R
    Carbon, C
    Moine, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) : 1575 - 1577
  • [8] PROPHYLACTIC AND THERAPEUTIC ACTIVITIES OF AZITHROMYCIN IN A MOUSE MODEL OF PNEUMOCOCCAL PNEUMONIA
    AZOULAYDUPUIS, E
    VALLEE, E
    BEDOS, JP
    MUFFATJOLY, M
    POCIDALO, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (06) : 1024 - 1028
  • [9] INVIVO EFFICACY OF A NEW FLUOROQUINOLONE, SPARFLOXACIN, AGAINST PENICILLIN-SUSCEPTIBLE AND PENICILLIN-RESISTANT AND MULTIRESISTANT STRAINS OF STREPTOCOCCUS-PNEUMONIAE IN A MOUSE MODEL OF PNEUMONIA
    AZOULAYDUPUIS, E
    VALLEE, E
    VEBER, B
    BEDOS, JP
    BAUCHET, J
    POCIDALO, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (12) : 2698 - 2703
  • [10] EFFICACY OF ANTI-MICROBIAL THERAPY IN EXPERIMENTAL RAT PNEUMONIA - EFFECTS OF IMPAIRED PHAGOCYTOSIS
    BAKKERWOUDENBERG, IAJM
    JONGHOENDEROP, JYTD
    MICHEL, MF
    [J]. INFECTION AND IMMUNITY, 1979, 25 (01) : 366 - 375